Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business & Regulation


Business & Regulation Business Practice

Business-In-Brief

| Maryam Mahdi

Drug pricing concerns, facility expansions and regulatory changes... What’s new for pharma in business?

Business & Regulation Technology and Equipment

Plug and Play for the Future

| Daniel McCarthy

Single-use biotech process equipment is already making use of technology to automate processes and the level of complexity is increasing.

Business & Regulation Business Practice

The Advocate

| Maryam Mahdi

Sitting Down With… Charles Gore, Executive Director, Medicines Patent Pool (MPP), Geneva, Switzerland.

Business & Regulation Business Practice

Zero Impact

| Dorethe Nielsen

Rethinking our approach to the use of energy and resources could help transform our relationship with the environment.

Business & Regulation Business Practice

The Patent Snatchers

| James Strachan

Can’t offer an “affordable” price? Then say goodbye to market exclusivity.

Business & Regulation Business Practice

Man Allegedly Praises Pharmaceutical Companies

| Stephanie Sutton

Joe Biden apparently dared say there were “great drug companies out there – except for a couple of opioid outfits.”

Business & Regulation Digital Technologies

Time to Pop It In!

| Timo Heikkilä

Timo Heikkilä COO at Popit, Finland, explains how technology can help boost patient compliance rates.

Business & Regulation Contract Development Services

Eyes on Outsourcing

| Stephanie Sutton

Catch up on the biggest trends in outsourcing with our infographic.

Business & Regulation Business Practice

On the Side of Caution

| Sue Springett

Sue Springett, Commercial Manager at Teknomek, explains the importance of health and safety in a solid coroporate social responsibility strategy.

Business & Regulation Supply Chain

A Whole Hog of Problems

| Maryam Mahdi

Six members of the US's congress demand answers from the FDA as the risk of heparin shortages loom.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register